Validation of single‐gene noninvasive prenatal testing for sickle cell disease
- 2 May 2022
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 97 (7) , E270-E273
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Heart, Lung, and Blood Institute
This publication has 7 references indexed in Scilit:
- It takes two: uptake of carrier screening among male reproductive partnersPrenatal Diagnosis, 2019
- A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPTScientific Reports, 2019
- The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translationCurrent Opinion in Hematology, 2017
- Gene Therapy in a Patient with Sickle Cell DiseaseNew England Journal of Medicine, 2017
- Committee Opinion No. 691: Carrier Screening for Genetic ConditionsObstetrics & Gynecology, 2017
- Fetal fraction in maternal plasma cell‐free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristicsUltrasound in Obstetrics & Gynecology, 2012
- Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?Cytotherapy, 2009